Skip to main content
OpenTrials

Clinical trial condition

Porphyria, Acute Intermittent

Explore clinical trials studying Porphyria, Acute Intermittent. Study availability and eligibility vary by location and protocol.

16 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Porphyria, Acute Intermittent trial results

Recruiting

Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment

NCT06273644

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Genetic Diseases, Inborn, +9 more
Locations
  • Nordland Hospital Trust Bodø, Nordland, Norway
  • Studieenheten, Akademiskt Specialistcentrum, Stockholm läns sjukvårdsområde, Region Stockholm Stockholm, Sweden
  • Norrland University Hospital Umeå, Sweden
View Trial Details
Completed

ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)

NCT03338816

Conditions
ALA Dehydratase Deficient Porphyria (ADP), Acute Hepatic Porphyria, Acute Intermittent Porphyria, +17 more
Locations
  • Clinical Trial Site Little Rock, Arkansas, United States
  • Clinical Trial Site San Francisco, California, United States
  • Clinical Trial Site Boston, Massachusetts, United States
  • Clinical Trial Site Ann Arbor, Michigan, United States
View all 36 locations
View Trial Details
Completed

A Study to Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP)

NCT02949830

Conditions
Acute Intermittent Porphyria, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +10 more
Locations
  • Clinical Trial Site San Francisco, California, United States
  • Clinical Trial Site New York, United States
  • Clinical Trial Site Galveston, Texas, United States
  • Clinical Trial Site Stockholm, Sweden
View Trial Details
Completed

Clinical Diagnosis of Acute Porphyria

NCT01568554

Conditions
Acute Intermittent Porphyria (AIP), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coproporphyria, Hereditary, +14 more
Locations
  • UAB Porphyria Center, University of Alabama at Birmingham Birmingham, Alabama, United States
  • UCSF Porphyria Center, University of California at San Francisco San Francisco, California, United States
  • Mount Sinai Porphyria Comprehensive Diagnostic & Treatment Center, Mount Sinai School of Medicine New York, United States
  • Wake Forest University School of Medicine Winston-Salem, North Carolina, United States
View Trial Details
Completed

A Phase 1 Study of Givosiran (ALN-AS1) in Patients With Acute Intermittent Porphyria (AIP)

NCT02452372

Conditions
Acute Intermittent Porphyria, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +10 more
Locations
  • Clinical Trial Site Birmingham, Alabama, United States
  • Clinical Trial Site San Francisco, California, United States
  • Clinical Trial Site New York, United States
  • Clinical Trial Site Galveston, Texas, United States
View Trial Details

Related conditions